Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets

December 10, 2020 -MolecuLight i:X will Provide Essential Real-Time Information to Assist Wound Care Plus’s Advanced Wound Care Consultants in Providing the Highest Quality Wound Care

Toronto, Canada and Midwest, USA – (December 10, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced that Wound

… Read More

Results Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%

November 25, 2020 -Results of Fluorescence Imaging Combined with Clinical Assessment

Toronto, Canada and London, UK – (November 25, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced the publication of results from a 2-year retrospective study of 229 foot ulcers in… Read More

Results from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment

September 29, 2020 -Fluorescence Imaging Use Led to Changes to 69% of Treatment Plans

Toronto, CANADA – (September 29, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announced publication of results from the Fluorescence Imaging Assessment and Guidance (“FLAAG”) clinical trial in… Read More

Latest Clinical Evidence Presented at SAWC 2020 Illustrates the Significant Utility of the MolecuLight i:X® for Visualizing Bacteria and Improving Clinical Outcomes

July 31, 2020 -10 Posters and Videos on Benefits of MolecuLight Device for Wound Care

Toronto, CANADA – (July 31, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the presentation of 10 Clinical Posters and Video Presentations at the Symposium of Wound

… Read More

MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence

June 11, 2020 -New Code Enables Reimbursement to Hospital Outpatient Centers Using MolecuLight i:X

Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has assigned an Ambulatory Payment Classification

… Read More